Truist Securities Maintains Hold on OrthoPediatrics, Raises Price Target to $28
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Truist Securities analyst Ravi Misra maintains OrthoPediatrics (NASDAQ:KIDS) with a Hold and raises the price target from $22 to $28.
Truist Securities analyst Ravi Misra maintains OrthoPediatrics (NASDAQ:KIDS) with a Hold and raises the price target from $22 to $28.
